Women’s Health Tracking Apps Need a Higher Standard

Women’s health tracking apps increasingly sit between daily experience and clinical care. They can organise cycle dates, pain, sleep, movement and medication into patterns that memory alone may miss. New research, however, highlights a central tension: more intimate data do not automatically produce better health decisions.

A 2026 paper in npj Women’s Health shows the constructive side of this technology. Researchers developed an artificial intelligence approach using wearable data to forecast prolonged sedentary periods in women with chronic pelvic pain disorders. In parallel, a 2026 BMJ analysis argues that digital menstrual tracking can cause harm without stronger scrutiny. Taken together, the papers suggest that the next phase of FemTech should be judged less by how much it collects and more by whether its outputs are valid, proportionate and genuinely useful.

Women’s health tracking apps can move from recording to forecasting

Most consumer tracking tools describe what has already happened. The pelvic pain study explored a more ambitious model: forecasting an upcoming sedentary bout from wearable signals, with an approach designed for on-device learning and real-time deployment. This could eventually support timely, context-sensitive prompts rather than generic reminders delivered on a fixed schedule.

The distinction matters in chronic pelvic pain. Sitting may be connected with pain, fatigue, work demands, sleep disruption or reduced activity, but a device can observe movement more readily than it can explain why movement changed. A forecast is therefore not a diagnosis, nor does it establish that sitting caused a pain flare. Its potential value lies in identifying a moment when an intervention might be relevant.

The verified paper, by Jegminat and colleagues, was published in npj Women’s Health in 2026. The supplied material does not report the sample size or clarify whether performance was tested prospectively outside the development setting. Those omissions limit conclusions about accuracy across different ages, conditions, bodies, occupations and wearable devices. A technically successful model can still perform unevenly when moved into everyday use.

Menstrual data require more than an accurate calendar

The BMJ paper by Lee and colleagues takes a broader critical view of digital menstrual tracking. It argues that these tools can create more harm than benefit and require closer scrutiny. The item is an expert analysis rather than a randomised trial, so it should not be read as proof that every app harms its users. It does identify important questions that product design often treats as secondary.

Menstrual information is unusually sensitive. A record of bleeding, missed periods, sexual activity or fertility intentions may reveal information about pregnancy, miscarriage, contraception, perimenopause or a health condition. Risks depend on what is collected, where it is stored, whether it is shared, and whether users can meaningfully delete or export it. Consent presented as a long legal document is not the same as informed control.

Interpretation is another concern. Cycle variation is normal, and a predicted fertile window is not equivalent to confirmed ovulation. Algorithms trained on regular cycles may be less dependable for people with irregular bleeding, polycystic ovary syndrome, endometriosis, postpartum changes or the hormonal variability of perimenopause. A confident interface can make an estimate appear more certain than the underlying evidence allows.

That does not make tracking inherently unhelpful. It means the output should preserve uncertainty and context. A symptom record becomes more informative when it distinguishes bleeding from pain, sleep, energy, digestion and medication changes rather than compressing everything into a single cycle score. The same principle underpins how perimenopause tracking works: recurring relationships can matter more than one isolated date or prediction.

Clinical usefulness depends on the question being asked

The strongest digital health tools start with a defined problem. In the pelvic pain paper, the target was a specific behaviour within a specific population: prolonged sitting among women with chronic pelvic pain disorders. That is narrower and more testable than claiming to optimise general wellbeing from an opaque composite score.

A useful system should also separate measurement from inference. Wearables measure proxies such as motion, heart rate or skin temperature. Apps collect self-reported experiences such as mood, cramps and fatigue. Neither stream is a complete account of health. Movement data may miss pain severity, while symptom ratings can be affected by recall, expectations and the timing of an entry. Combining them may improve context, but it can also multiply uncertainty if the model is not transparent.

Validation should therefore match the intended use. A low-stakes reflection tool needs clear limitations. A fertility estimate, medication prompt or clinical risk flag requires substantially stronger evidence, including performance across relevant groups and testing in real-world conditions. False reassurance and unnecessary alarm are both meaningful harms in women’s health, where symptoms are already vulnerable to dismissal or oversimplification.

Human factors matter as much as model accuracy. Notifications that arrive at the wrong time can create burden, shame or alert fatigue. A prediction about prolonged sitting may be accurate but unactionable for someone unable to leave a desk, vehicle or care setting. Personalisation should include whether an intervention is feasible, not merely whether an event is predictable.

Better FemTech will be private, interpretable and longitudinal

These papers point toward a more demanding standard for FemTech. Data collection should be minimised rather than maximised. Sensitive information should have clear retention and deletion controls. Predictions should show what they can and cannot establish. Products should be tested in the populations for whom they are intended, including women with irregular cycles, chronic conditions and changing hormonal states.

Longitudinal context is especially important. One night of poor sleep or one painful cycle rarely resolves a clinical question. Repeated observations can show whether pelvic pain tends to coincide with prolonged sitting, whether energy shifts before bleeding, or whether sleep disruption precedes worse symptoms. This is also where Tulsy compared with wearables becomes a useful distinction: passive sensor data and subjective daily signals answer different questions and are often most informative when interpreted together.

Even then, correlation is not causation. A recurring association can support a more focused conversation or a carefully monitored change, but it does not prove mechanism. Good tracking narrows questions instead of pretending to settle them.

Pelvic pain, sitting time, cycle symptoms and related sleep or energy changes only become readable when they are logged consistently over weeks. This is the kind of pattern Tulsy is built to surface.

Sources: Medical Xpress.

This content is for informational and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease, and should not replace advice from a qualified healthcare professional.